Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

The combination of cyproterone acetate and testosterone enanthate is highly effective in preventing sperm production and could be a good reversible male contraceptive.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

Ketoconazole reduced hair growth and improved acne in women, but caused side effects needing careful monitoring.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Plant-based drugs are effective and safe alternatives for managing PCOS symptoms.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

Quercetin may help with PCOS symptoms, but more research is needed.

Some plants used in traditional medicine may help treat cancer because they contain proteins that can inactivate ribosomes.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

New treatments aim to improve thin endometrium to help more couples with infertility.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Menopause affects hair and skin; more research needed for treatment.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.